NL990041I1 - Oftalmische samenstellingen die combinaties van een carbonanhydraseremmer en een beta-adrenergische antagonist bevatten. - Google Patents

Oftalmische samenstellingen die combinaties van een carbonanhydraseremmer en een beta-adrenergische antagonist bevatten.

Info

Publication number
NL990041I1
NL990041I1 NL990041C NL990041C NL990041I1 NL 990041 I1 NL990041 I1 NL 990041I1 NL 990041 C NL990041 C NL 990041C NL 990041 C NL990041 C NL 990041C NL 990041 I1 NL990041 I1 NL 990041I1
Authority
NL
Netherlands
Prior art keywords
beta
compositions containing
adrenergic antagonist
ophthalmic compositions
containing combinations
Prior art date
Application number
NL990041C
Other languages
English (en)
Other versions
NL990041I2 (nl
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27103852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL990041(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NL990041I1 publication Critical patent/NL990041I1/nl
Publication of NL990041I2 publication Critical patent/NL990041I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL990041C 1991-04-17 1999-12-01 Oftalmische samenstellingen die combinaties van een carbonanhydrseremmer en een beta-adrenergische antagonist bevatten. NL990041I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68671891A 1991-04-17 1991-04-17
US83491392A 1992-02-13 1992-02-13

Publications (2)

Publication Number Publication Date
NL990041I1 true NL990041I1 (nl) 2000-02-01
NL990041I2 NL990041I2 (nl) 2000-04-03

Family

ID=27103852

Family Applications (1)

Application Number Title Priority Date Filing Date
NL990041C NL990041I2 (nl) 1991-04-17 1999-12-01 Oftalmische samenstellingen die combinaties van een carbonanhydrseremmer en een beta-adrenergische antagonist bevatten.

Country Status (25)

Country Link
EP (1) EP0509752B1 (nl)
JP (1) JP2527513B2 (nl)
KR (1) KR920019348A (nl)
CN (1) CN1073421C (nl)
AT (1) ATE182787T1 (nl)
AU (1) AU648659C (nl)
CA (1) CA2065965C (nl)
CH (1) CH0509752H1 (nl)
CY (1) CY2146B1 (nl)
CZ (1) CZ285129B6 (nl)
DE (3) DE69229688C5 (nl)
DK (1) DK0509752T3 (nl)
ES (1) ES2133304T3 (nl)
GR (1) GR3031467T3 (nl)
HK (1) HK1009251A1 (nl)
IE (1) IE921240A1 (nl)
IL (1) IL101537A (nl)
LU (1) LU90506I2 (nl)
MX (1) MX9201785A (nl)
NL (1) NL990041I2 (nl)
NO (1) NO306196B1 (nl)
RO (1) RO113612B1 (nl)
SK (1) SK282039B6 (nl)
WO (1) WO1992018124A1 (nl)
YU (1) YU39392A (nl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118941T3 (es) * 1992-02-21 1998-10-01 Alcon Lab Inc Composiciones antiglaucoma topicas que comprenden inhibidores de anhidrasa carbonica y bloqueantes beta.
US5932572A (en) * 1992-02-21 1999-08-03 Alcon Laboratories, Inc. Topical anti-glaucoma compositions
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
FI981473A (fi) * 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
CN100345594C (zh) * 2004-01-19 2007-10-31 无锡杰西医药科技有限公司 乙酰唑胺滴眼液
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
DK2598118T3 (en) 2010-07-29 2018-12-10 Allergan Inc CONSERVATIVE-FREE BIMATOPROST AND TIMOLOL SOLUTIONS
JP5893204B1 (ja) * 2015-02-23 2016-03-23 参天製薬株式会社 防腐効果のある医薬の組合せ
TW201726127A (zh) * 2016-01-29 2017-08-01 參天製藥股份有限公司 含有多佐胺、高分子及硼酸之醫藥組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use

Also Published As

Publication number Publication date
AU1497992A (en) 1992-10-22
IL101537A0 (en) 1992-12-30
CZ209893A3 (en) 1994-06-15
ES2133304T3 (es) 1999-09-16
NO933714D0 (no) 1993-10-15
DE10075002I2 (de) 2004-07-01
GR3031467T3 (en) 2000-01-31
JP2527513B2 (ja) 1996-08-28
CH0509752H1 (nl) 2012-11-30
NO306196B1 (no) 1999-10-04
WO1992018124A1 (en) 1992-10-29
IL101537A (en) 1997-11-20
AU648659C (en) 2008-02-14
CN1073421C (zh) 2001-10-24
DE69229688C5 (de) 2010-10-21
HK1009251A1 (en) 1999-05-28
LU90506I2 (fr) 2000-03-28
NL990041I2 (nl) 2000-04-03
DE69229688D1 (de) 1999-09-09
DE69229688T4 (de) 2010-08-19
AU648659B2 (en) 1994-04-28
DE10075002I1 (de) 2000-03-30
DK0509752T3 (da) 1999-12-06
YU39392A (sh) 1995-12-04
SK110393A3 (en) 1994-02-02
EP0509752B1 (en) 1999-08-04
DE69229688T2 (de) 2000-02-24
CA2065965A1 (en) 1992-10-18
RO113612B1 (ro) 1998-09-30
CN1066781A (zh) 1992-12-09
ATE182787T1 (de) 1999-08-15
JPH05117167A (ja) 1993-05-14
EP0509752A3 (en) 1993-03-03
EP0509752A2 (en) 1992-10-21
NO933714L (no) 1993-10-15
IE921240A1 (en) 1992-10-21
KR920019348A (ko) 1992-11-19
SK282039B6 (sk) 2001-10-08
CA2065965C (en) 1998-06-16
CY2146B1 (en) 2002-06-21
MX9201785A (es) 1992-10-01
CZ285129B6 (cs) 1999-05-12

Similar Documents

Publication Publication Date Title
DK0608353T3 (da) Vandig, kosmetisk gel med lav pH-værdi og indeholdende ikke-ioniske polyacrylamidderivater
DE59310146D1 (de) Sulfonamidocarbonylpyridin-2-carbonsäureamide und ihre Verwendung als Arzneimittel
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
NL990041I1 (nl) Oftalmische samenstellingen die combinaties van een carbonanhydraseremmer en een beta-adrenergische antagonist bevatten.
DE69418947T2 (de) Stilbenderivate und analoga sowie deren anwendung
DE69116705D1 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
DE69312319T2 (de) Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
ATE98647T1 (de) Substituierte thieno(2,3-b) thiophen-2sulfonamide als mittel gegen glaukoma.
ITMI910913U1 (it) Portaombrelli portatile, in particolare per l'utilizzo all'interno di autovetture
ITMI910265A1 (it) Impiego di antagonisti dei recettori del trombossano nel trattamento di disfunzioni della vescica urinaria dell'uomo
ITBO950086A0 (it) Uso di 2, 3-diidro-4(1h)-chinazolinoni e di composizioni farmaceutiche che li contengono nel trattamento dei disturbi dell'apprendimento e della memoria
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
IT1225800B (it) Polarizzatore doppio, per l'osservazione dei cinescopi in genere
ITTE930001A1 (it) Procedimento per l'arricchimento del tenore in zeoliti di sottoprodotti delle cave di blocchetti di "tufo litoide"
KR880015723U (ko) 절첩식의자의 지각연결장치